Dependence on zolpidem: Two case reports of detoxification with flumazenil infusion

International Clinical Psychopharmacology

Volumn 20, Issue 5, 2005, Pages 285-287

  Quaglio, GianLuca ^a   Lugoboni, Fabio ^a   Fornasiero, Anna ^a   Lechi, Alessandro ^a   Gerra, Gilberto ^b   Mezzelani, Paolo ^a  

^a UNIVERSITY OF VERONA   (Italy)

^b AUSL   (Italy)

Author keywords

Clinical management; Dependence; Detoxification; Flumazenil; Zolpidem

Indexed keywords

ALPRAZOLAM; ANTIDEPRESSANT AGENT; BACLOFEN; BENZODIAZEPINE DERIVATIVE; CLOBAZAM; CLONAZEPAM; FLUMAZENIL; FLUOXETINE; HALOPERIDOL; NEUROLEPTIC AGENT; PAROXETINE; SERTRALINE; ZOLPIDEM;

ADULT; ANAMNESIS; ANXIETY; ARTICLE; ASTHENIA; CASE REPORT; DEPRESSION; DRUG DEPENDENCE; DRUG DETOXIFICATION; DRUG HALF LIFE; DRUG TOLERANCE; DRUG WITHDRAWAL; HUMAN; INSOMNIA; MALE; PANIC; PRIORITY JOURNAL; TREATMENT FAILURE; WITHDRAWAL SYNDROME;

ADULT; ANTIDOTES; FLUMAZENIL; HALF-LIFE; HUMANS; HYPNOTICS AND SEDATIVES; INFUSIONS, INTRAVENOUS; MALE; PYRIDINES; SUBSTANCE-RELATED DISORDERS;

EID: 23944484494     PISSN: 02681315     EISSN: None     Source Type: Journal    
DOI: 10.1097/01.yic.0000166404.41850.b4     Document Type: Article

References (16)

1. Buhr A, Schaerer MT, Sigel E (1997). A point mutation in the gamma-2 subunit of gamma-aminobutyric acid type A receptors results in altered benzodiazepine binding site specificity. Proc Natl Acad Sci USA 94:8824-8829.
2. Boulanger-Rostowsky L, Fayet H, Benmoussa N, Ferrandi J (2004). Dependence on zolpidem: a report of two cases. L'Encéphale 30:153-155.
3. Gerra G, Giucasto G, Zaimovic A, Fertonani G, Chittolini B, Avanzini P, et al. (1996). Intravenous flumazenil following prolonged exposure to lormetazepam in humans: lack of precipitated withdrawal. Int Clin Psychopharmacol 11:81-88.
4. Gerra G, Zaimovic A, Giusti F, Moi G, Brewer C (2002). Intravenous flumazenil versus oxazepam tapering in the treatment of benzodiazepine withdrawal: a randomized, placebo-controlled study. Addict Biol 7:385-395.
5. Hajak G, Muller WE, Wittchen HU, Pittrow D, Kirch W (2003). Abuse and dependence potential for the non-benzodiazepine hypnotics zolpidem and zopiclone: a review of case reports and epidemiological data. Addiction 98:1371-1378.
6. A receptors expressed in stably transfected cells. J Neurochem 63:2349-2352.
7. Liappas IA, Malitas PN, Dimopoulos NP, Gitsa OE, Liappas AI, Nikolaou ChK, et al. (2003). Zolpidem dependence case series: possible neurobiological mechanisms and clinical management. J Psychopharmacol 17:131-135.
8. Madrak LN, Rosenberg M (2001). Zolpidem abuse. Am J Psychiatry 158: 1330-1331.
9. Mitler MM (2000) Nonselective and selective benzodiazepine receptor agonists-where are we today? Sleep 23 (suppl 1):S39-S47.
10. Primus RJ, Yu J, Xu J, Hartnett C, Meyyappan M, Kostas C, et al. (1996). Allosteric uncoupling after chronic benzodiazepine exposure of recombinant gamma-aminobutyric acid(A) receptors expressed in Sf9 cells: ligand efficacy and subtype selectivity. J Pharmacol Exp Ther 276:882-890.
11. A receptor subunit for benzodiazepine pharmacology. Nature 338:582-585.
12. Rappa LR, Larose-Pierre M, Payne DR, Eraikhuemen NE, Lanes DM, Kearson ML (2004). Detoxification from high-dose zolpidem using diazepam. Ann Pharmacother 38:590-594.
13. Ravishankar A, Carnwath T (1998). Zolpidem tolerance and dependence: two case reports. J Psychopharmacol 12:103-104.
14. Rush CR, Baker RW, Wright K (1999). Acute behavioral effects and abuse potential of trazodone, zolpidem and triazolam in humans. Psychopharmacology 144:220-233.
15. Sakkas P, Psarros C, Masdrakis V, Liappas J, Christodoulou GN (1999). Dependence on zolpidem: a case report. Eur Psychiatry 14:358-359.
16. Saxon L, Hjemdahl P, Hiltunen AJ, Borg S (1997). Effects of flumazenil in the treatment of benzodiazepine withdrawal: a double-blind pilot study. Psychopharmacology 131: 153-160.